Leaflet BITUB 100mg / ml solution for injection


Indicated for: tuberculosis

Route of administration: injectable

Substance: isoniazid (anti-tuberculosis agent)

ATC: J04AC01 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Hydrazides)

Isoniazid is an antibiotic used for the treatment and prevention of tuberculosis. It works by inhibiting the synthesis of the cell wall of Mycobacterium tuberculosis, thereby killing the microorganism.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to complete the treatment duration to prevent the development of bacterial resistance.

Side effects may include nausea, vomiting, peripheral neuropathy, or elevated liver enzymes. In rare cases, severe hepatitis or allergic reactions may occur.

Isoniazid is not recommended for patients with severe hepatic impairment or hypersensitivity to this medication.

General data about BITUB 100mg / ml

  • Substance: isoniazid
  • Date of last drug list: 01-12-2020
  • Commercial code: W60594001
  • Concentration: 100mg / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 10
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: YURIA-PHARM LTD. - UCRAINA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 406/2019/01
  • Shelf life: 1.5 years

Pharmaceutical forms available for isoniazid

Concentrations available for isoniazid

  • 100mg
  • 100mg/5ml
  • 100mg/ml
  • 300mg
  • 500mg/10ml